Reduction of Myocardial Scar Size after Implantation of Mesenchymal Stem Cells in Rats: What Is the Mechanism?
- 1 June 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in Stem Cells and Development
- Vol. 14 (3) , 299-309
- https://doi.org/10.1089/scd.2005.14.299
Abstract
The use of a cellular therapy offers a promising approach for the treatment of heart disease. Besides other precursor cells, bone marrow (BM)-derived stem cells were discovered that migrate into ischemic myocardium and participate in myogenesis as well as angiogenesis. A subpopulation of those are the mesenchymal stem cells (MSC), which may be potential candidates for repairing ischemic heart tissue. MSC are easy to prepare and can be used in an autologous strategy. Here we demonstrate the effect of transplanted MSC in our autologous rat model of myocardial injury. BM was isolated from tibiae and femurs of Wistar rats. After 24 h, the adhering MSC were separated, expanded, retrovirally transduced using green fluorescent protein (GFP), and cloned. A cryo-infarct was generated in the rat hearts, and immediately after this the cells were injected into the border zone of the lesion. After a 10-week follow up, the hearts were excised and the myocardial scar areas were measured using computer-guided morphometry. When comparing transplanted rats (n = 8) with control animals (n = 5) treated rats demonstrated a significant reduction in the width (p < 0.05) of the myocardial scar area. The depth of the scars of the cell therapy rats was less extended (p > 0.05) and the myocardium of these animals was thicker than in the controls (p > 0.05). Immunohistochemical analyses revealed neither evidence of MSC transdifferentiation into cardiomyocytes, nor could an increased neovascularization be found. In conclusion, MSC are responsible for a remarkable reduction of the myocardial scar size in the treated animals. But, whether this strategy is directly transferable to the patient suffering from heart disease has to be determined. In addition, the mechanism by which MSC act in the ischemic heart remains to be determined.Keywords
This publication has 54 references indexed in Scilit:
- Role of stem cell homing in myocardial regenerationInternational Journal of Cardiology, 2004
- Stem Cell Repair of Infarcted MyocardiumCirculation, 2003
- Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantationThe Lancet, 2003
- Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effectsThe Annals of Thoracic Surgery, 2002
- Mobilized bone marrow cells repair the infarcted heart, improving function and survivalProceedings of the National Academy of Sciences, 2001
- Bone marrow cells regenerate infarcted myocardiumNature, 2001
- Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac functionNature Medicine, 2001
- Myoblast transplantation for heart failureThe Lancet, 2001
- Erratum: Regenerating functional myocardium: Improved performance after skeletal myoblast transplantationNature Medicine, 1998